CT-P47 (tocilizumab biosimilar) - Celltrion
CMAB816 (canakinumab biosimilar) - Mabpharm Limited
Still's Now - Journal Club - Jul 24, 2022 - Pres time: Jul 26, 2022; 06:00 PM; "Join Drs. Jack Cush...for this week's Journal Club, which will discuss the following two articles: CONSIDER Trial. Canakinumab for Treatment of Adult-Onset Still's Disease...Tocilizumab in systemic juvenile idiopathic arthritis..." 
Live event
https://us02web.zoom.us/webinar/register/WN_ehpdNDdZTo6P6fGdQvNvbA
 
Jul 24, 2022